0001144204-14-054820.txt : 20140908
0001144204-14-054820.hdr.sgml : 20140908
20140908160238
ACCESSION NUMBER: 0001144204-14-054820
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140829
FILED AS OF DATE: 20140908
DATE AS OF CHANGE: 20140908
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alliqua BioMedical, Inc.
CENTRAL INDEX KEY: 0001054274
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 582349413
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 CABOT BOULEVARD WEST
CITY: LANGHORNE
STATE: PA
ZIP: 19047
BUSINESS PHONE: 215-702-8550
MAIL ADDRESS:
STREET 1: 2150 CABOT BOULEVARD WEST
CITY: LANGHORNE
STATE: PA
ZIP: 19047
FORMER COMPANY:
FORMER CONFORMED NAME: Alliqua, Inc.
DATE OF NAME CHANGE: 20101222
FORMER COMPANY:
FORMER CONFORMED NAME: HEPALIFE TECHNOLOGIES INC
DATE OF NAME CHANGE: 20030529
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA CORP
DATE OF NAME CHANGE: 20030219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BARTON BRADFORD
CENTRAL INDEX KEY: 0001618553
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36278
FILM NUMBER: 141091042
MAIL ADDRESS:
STREET 1: C/O ALLIQUA BIOMEDICAL, INC.
STREET 2: 2150 CABOT BLVD. WEST
CITY: LANGHORNE
STATE: PA
ZIP: 19047
3
1
v388699_3.xml
OWNERSHIP DOCUMENT
X0206
3
2014-08-29
0
0001054274
Alliqua BioMedical, Inc.
ALQA
0001618553
BARTON BRADFORD
C/O ALLIQUA BIOMEDICAL, INC.
2150 CABOT BOULEVARD WEST
LANGHORNE
PA
19047
0
1
0
0
Chief Operating Officer
Common Stock
15210
D
Stock Option (right to buy)
4.38
2023-05-10
Common Stock
54855
D
Stock Option (right to buy)
5.47
2023-05-10
Common Stock
54855
D
Stock Option (right to buy)
6.56
2023-05-10
Common Stock
54855
D
Stock Option (right to buy)
8.75
2023-05-10
Common Stock
54855
D
Stock Option (right to buy)
10.94
2023-05-10
Common Stock
54855
D
Stock Option (right to buy)
9.00
2024-03-06
Common Stock
70000
D
Warrant (right to buy)
4.24
2013-06-28
2018-06-28
Common Stock
9877
D
The number of shares and prices reported in this Form 4 reflect a 1-for-43.75 reverse stock split of the common stock of the Issuer that occurred on November 18, 2013.
Represents a single option granted on May 10, 2013 in five separate tranches. Each tranche vests in three equal annual installments, with one-third (1/3rd) vesting on May 10, 2013, May 17, 2014 and May 17, 2015, subject to Mr. Barton's continued service with the Issuer on the applicable vesting date.
The option vests in three equal annual installments, with one-third (1/3rd) vesting on March 6, 2015, 2016 and 2017, subject to Mr. Barton's continued service with the Issuer on the applicable vesting date.
/s/Bradford Barton
2014-09-08